UK's chief scientific adviser has £600k shareholding in firm contracted to develop vaccines
The UK’s chief scientific adviser Sir Patrick Vallance has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, The Telegraph has revealed.
In July, GlaxoSmithKline (GSK) and drugs multinational Sanofi agreed a deal with the UK Government to supply it with up to 60 million doses of Covid-19 vaccine, subject to final contract.
It has a similar deal with the US Government for an initial 100 million doses.
The UK’s chief scientific adviser Sir Patrick Vallance has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, The Telegraph has revealed.
In July, GlaxoSmithKline (GSK) and drugs multinational Sanofi agreed a deal with the UK Government to supply it with up to 60 million doses of Covid-19 vaccine, subject to final contract.
It has a similar deal with the US Government for an initial 100 million doses.